Cite
MLA Citation
A D'Urzo et al.. “P252 Once-daily NVA237 improves symptoms, and reduces COPD exacerbations and associated hospitalisations: the GLOW1 trial.” Thorax, vol. 66, n.d., p. A170. http://access.bl.uk/ark:/81055/vdc_100144719229.0x000035